Peer-reviewedLicence not statedPsychopharmacology Bulletin
Piloting New Medications for Borderline Personality Disorder: The Use of Artificial Intelligence in Psychopharmacological Research
Related
- Canine-Assisted Interventions and Symptoms Associated with Borderline Personality Disorder: A Scoping Review
- Machine Learning in the Differential Diagnosis of Bipolar and Borderline Personality Disorders: A Scoping Review
- Borderline personality disorder, a diagnosis that cannot be challenged: If rejecting the diagnosis is a symptom, can the diagnosis ever be wrong? A response to Chazhoor and Younger (2026)
- Association of Borderline Personality Traits and Impulsivity with Problem Gambling Severity in Gambling Disorder
- Sociodemographic and clinical predictors in patients with borderline personality disorder: A 12-month follow-up study
BibTeX
@article{lazzari2026piloting,
title = {{Piloting New Medications for Borderline Personality Disorder: The Use of Artificial Intelligence in Psychopharmacological Research}},
author = {Carlo Lazzari and Marco Rabottini},
journal = {Psychopharmacology Bulletin},
year = {2026},
month = oct,
doi = {10.64719/pb.21597},
url = {https://doi.org/10.64719/pb.21597},
}
RIS
TY - JOUR
TI - Piloting New Medications for Borderline Personality Disorder: The Use of Artificial Intelligence in Psychopharmacological Research
AU - Carlo Lazzari
AU - Marco Rabottini
PY - 2026
DA - 2026/10/30
JO - Psychopharmacology Bulletin
DO - 10.64719/pb.21597
UR - https://doi.org/10.64719/pb.21597
SN - 0048-5764
SN - 2472-2448
ER -